Partner with us

Join forces to shape healthcare’s data-driven future
pink dots icon
As a global leader in data-driven medicine, SOPHiA GENETICS strives to break data silos and nurture knowledge sharing among healthcare professionals. We strongly believe that the right information in the right hands at the right time yields better health solutions with confidence. To make healthcare truly data-driven, we collaborate with like-minded industry partners and biopharma companies that share our vision to welcome a new era in medicine, to help better understand diseases today that will benefit individuals of tomorrow.

Our partnering areas of interest

In our vision of data-driven medicine, robust disease characterization through aggregated, multimodal data enables personalized care throughout an individual’s treatment journey. For instance, in oncology we aim to assess tumor evolution by combining tumor profiling at the molecular level with longitudinal follow-up using radiomic, pathology, laboratory, and clinical data.

Each institution within the SOPHiA GENETICS community gains knowledge and insights to improve their expertise in treating disease. Therefore, the aggregated insights from anonymized data across institutions create a collective intelligence on multiple disorders. This further supports confident, informed decision-making and can accelerate the discovery and improvement of targeted therapeutics.

To fully leverage this potential requires a decentralized approach enabling any permissioned user to produce and share data and derive insights through a secure cloud platform.

This approach can be applied across many disease areas. SOPHiA GENETICS has specific interest in oncology, rare disease, cardiology, neurology, and metabolism.

Why partner with us?

At SOPHiA GENETICS, we believe in the power of collaboration. We build long-term relationships for unique value, from deep expertise in genomic insight generation and multiple data modality analysis and interpretation to clinical trial matching and access to innovative technologies. Our partnerships focus on acceleration of clinical research and precision medicine discoveries.

Our Featured Partners

“The integration of genomics-based artificial intelligence into oncology workflow solutions would be a major breakthrough for integrated cancer medicine and for future clinical research, which increasingly depend on the ability to select those patients most likely to respond to new therapies,” said Jan Makela, President & CEO, Imaging at GE Healthcare. ”This collaboration [with SOPHiA GENETICS] represents another step in GE Healthcare’s vision of making precision health — more efficient and personalized care — a reality.”

Jan Makela, President & CEO
– GE Healthcare

“SOPHiA GENETICS is a leader in precision medicine,” said Keiji Kojima, Executive Vice President and Executive Officer, and General Manager of Smart Life Business Management Division of Hitachi, Ltd. “Hitachi is excited to start long term partnership with SOPHiA GENETICS to co-create innovative solutions for improving Quality of Life of patients by leveraging both companies’ data analytics and AI technologies.”

Keiji Kojima, Executive Vice President, Executive Officer, & General Manager of Smart Life Business Management Division
– Hitachi

This information is as of the date of the press announcement on March 25, 2021.

On July 8, 2021, SOPHiA GENETICS announced it has been named a finalist for the 2021 Microsoft Partner of the Year Award in Healthcare. The company was honored among a global field of top Microsoft partners for demonstrating excellence in innovation and implementation of customer solutions based on Microsoft technology. The Microsoft Partner of the Year Awards recognize Microsoft partners that have developed and delivered outstanding Microsoft-based solutions during the past year. Awards were classified in various of categories, with honorees chosen from a set of more than 4,400 submitted nominations from more than 100 countries worldwide.

“These remarkable partners have displayed a deep commitment to building world-class solutions for customers — from cloud-to-edge — and represent some of the best and brightest our ecosystem has to offer,” said Rodney Clark, Corporate Vice President of Global Partner Solutions in Channel Sales and Channel Chief at Microsoft.

Rodney Clark, Corporate Vice President of Global Partner Solutions in Channel Sales & Channel Chief
– Microsoft

“Genomics research is enabling a shift from a broad-based one-size-fits-all approach to a personalized experience. Pairing our industry-leading, rapidly customizable enrichment efficiency with SOPHiA GENETICS robust analytical platform provides customers an important solution to achieve clinically actionable data while saving on sequencing costs. We are excited to work with SOPHiA GENETICS to provide this new combined offering to clinical researchers around the world.”

Emily M. Leproust, Ph.D., CEO and Co-founder
– Twist Bioscience

pink dots icon

Ready to discuss a potential partnering opportunity?

We vigilantly monitor the market for potential investments to expand or add key technologies to our offerings that we believe will improve our platform’s ability to address our customers’ needs and catalyze the commercialization of new products and services.

We would like to meet and discuss how we might collaborate and add value through partnership. Please let us know how to reach you by completing the form below or email us at [email protected]. In addition, let us know if we can connect at an upcoming event.